期刊文献+

对激素抗拒的前列腺癌的联合化疗 被引量:5

Combination chemotherapy with adriamycin, mitomycin,5 fluorouracil for hormone refractory prostate cancer
原文传递
导出
摘要 目的 探讨阿霉素、丝裂霉素、5氟尿嘧啶联合化疗对激素抗拒的前列腺癌的疗效。 方法 1995 年4 月至1998 年7 月治疗15 例对激素抗拒的前列腺癌病人。随访5 ~24 个月,平均10个月。 结果 CR1 例,PR2 例,SD9 例。CR 和PR 持续6 ~18 个月,平均11 个月,CR、PR 及SD持续5 ~24 个月,平均9 个月。脱发、恶心呕吐、骨髓抑制是主要副反应。 结论 阿霉素、丝裂霉素、5氟尿嘧啶联合化疗方案可以延缓部分对激素抗拒的前列腺癌的进展。 Objective To evaluate the therapeutic efficacy of combination chemotherapy with adriamycin,mitomycin and 5 fluorouracil for hormone refractory prostate cancer. Methods From April,1995 to July,1998, 15 cases of hormone refractoty prostate cancer were treated with a combination chemotherapy using adriamycin,mitomycin and 5 fluorouracil.Therapeutic response was evaluated using standard solid tumor response criteria. Results There were 1 complete response,2 partial responses and 9 stable diseases.The duration of complete response and partial response was 6~18 months ( mean 11 months ).The total response duration for CR,PR and SD was 5~24 months with a mean of 9 months.Reversible alopecia,myelosuppression,nausea and vomiting were the toxicities noted. Conclusions Combination chemotherapy with adriamycin, mitomycin, and 5 fluorouracil might be helpful for cases of hormone refractory prostate cancer.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 1999年第10期625-627,共3页 Chinese Journal of Urology
关键词 前列腺肿瘤 联合化疗 药物疗法 Prostatic neoplasms Carcinoma Combination chemotherapy
  • 相关文献

参考文献2

  • 1孙燕 吴阶平.泌尿男生殖系肿瘤内科治疗.泌尿外科,第1版[M].济南:山东科学技术出版社,1995.1070-1096.
  • 2孙燕,泌尿外科,1995年,1070页

同被引文献54

  • 1鲍镇美.前列腺癌的治疗[J].中华泌尿外科杂志,1997,18(5):315-320. 被引量:28
  • 2Jemal A,Tiwari R,Murray T,et al.Cancer statistics,2004.CA Cancer J C1in,2004,54:8-29.
  • 3Bray F,Sankila R,Ferlay J,Parkin DM.Estimates of cancer incidence and mortality in Europe in 1995[J].Eur J Cancer,2002,38;99-166.
  • 4Geenle RT,Hill-Harmon MB,Murray T,Thur M.Cancer statistics[J].CA Cancer J Clin,2001,51:15-36.
  • 5Johansson JE,Andren O,Andersson SO,et al.Natural history of early,localized prostate cancer[J].JAMA,2004,29l:2713-2719.
  • 6Bill-Axelson A,Holmberg L,Ruutu M,et al.Radjcal prostatectomy versus watchful waiting in early prostate cancer[J].N Engl J Med,2005,352:1977-1984.
  • 7Carter HB,Walsh PC,Landis P,et al.Expectant man agement of nonpalpable prostate cancer with curative intent:preliminary results[J].J Urol,2002,167:1231-1234.
  • 8Choo R,K1otz L,Dadjoux C,et al.Feasibility study:watchful waiting for localized 1ow to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen,histological and/or clinical progression[J].J Uro1,2002,167:1664-1669.
  • 9Van Poppel H,Goethuys H,Callewaert P,Vanuytsel L,Van de Voorde WM,BaertI.Radical prostatectomy can provide a cure for well-selected clinical stage T3 prostate cancer[J].Eur Urol,2000,38:372-379.
  • 10Huland H.Treatment of localized disease:treatment of clinically 1ocalized prostate cancer(Tl/T2).In:Proceedings of the First International Consultation on Prostate Cancer,Scientific Communication International Ltd.Jersey[J].Channel islands,1997,227-257.

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部